Laverock Therapeutics Limited

DataGardener
live
Small

Laverock Therapeutics Limited

13508159•Private Limited With Share Capital

C/O Xeinadin, First Floor Secure House, Chandler'S Ford, SO533TL
Incorporated

13/07/2021

Company Age

5 years

Directors

6

Employees

29

SIC Code

72110

Risk

high risk

Company Overview

Registration, classification & business activity

Laverock Therapeutics Limited (13508159) is a private limited with share capital incorporated on 13/07/2021 (5 years old) and registered in chandler's ford, SO533TL. The company operates under SIC code 72110 - research and experimental development on biotechnology.

Next generation programmable cell therapies

Private Limited With Share Capital
SIC: 72110
Small
Incorporated 13/07/2021
SO533TL
29 employees

Financial Overview

Total Assets

£7.48M

Liabilities

£772.5K

Net Assets

£6.71M

Est. Turnover

£2.20M

AI Estimated
Unreported
Cash

£4.26M

Key Metrics

29

Employees

6

Directors

154

Shareholders

4

Patents

Board of Directors

5

Innovate Grants

4

This company received a grant of £689672.0 for Evaluation Of A Programmable Immune Cell Therapy For Solid Tumours. The project started on 01/10/2023 and ended on 30/09/2025.

This company received a grant of £498362.0 for Programmable Gene Silencing: Non-Disruptive Mirna Harnessing In The Design Of A Candidate Cell Therapy. The project started on 01/10/2025 and ended on 30/06/2027.

+2 more grants available

Import / Export

Imports
12 Months9
60 Months43
Exports
12 Months0
60 Months2

Risk Assessment

high risk

International Score

Future Factor

excellent

Performance Rating

Accounts

Typesmall company
Due Date30/09/2027
Filing Date14/05/2026
Latest Accounts31/12/2025

Trading Addresses

C/O Xeinadin, First Floor Secure House, Chandler'S Ford, So53 3Tl, SO533TLRegistered
Apex Building, 6 St Pancras Way, London, NW10TB

Contact

C/O Xeinadin, First Floor Secure House, Chandler'S Ford, SO533TL